MedTrace Logo

Diltiazem Gel Versus Nitroglycerin Ointment in Healing Process of Scleroderma Digital Ulcers

NCT02801305 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2017-03-06

No results posted yet for this study

Summary

Digital ulcers are one of the most prevalent complications of scleroderma (systemic sclerosis). There can be found few surveys on effect of topical agents on healing process of the ulcers. Thus, the aim of this study is to assess and compare the effects of topical diltiazem on SSc digital ulcers versus topical nitroglycerin.

Conditions

  • Digital Ulcer of Scleroderma

Interventions

DRUG

Diltiazem Gel 2%

This a topical agent which will be applied on digital ulcers by scleroderma patients.

DRUG

Nitroglycerin Ointment 2%

This a topical agent which will be applied on digital ulcers by scleroderma patients.

DRUG

Vaseline

This is used as the topical placebo agent.

Sponsors & Collaborators

  • Shiraz University of Medical Sciences

    collaborator OTHER

  • Mohammad Ali Nazarinia

    lead OTHER

Principal Investigators

  • Mohammad Ali Nazarinia, M.D. · Shiraz Geriatric Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2017-01-31
Completion
2017-03-31

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02801305 on ClinicalTrials.gov